Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Best of the 16th WCLC in Athens, Greece
lungcanc
First Congress of Interventional Pulmonology & EBUS and the XI South American Bronchology Congresses
Highlights From the 2019 IASLC Latin American Conference in Lung Cancer
IASLC WCLC 2016: Active Prevention, Accurate Diagnosis, Advanced Care
EGFR-Targeted Therapy: A New Beginning
2016 ASCO Annual Meeting
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
lungcanc
WCLC 2016 Together Against Lung Cancer
lungcanc
7th IASLC Latin American Conference on Lung Cancer
lungcanc
The Long Road Home
lungcanc
The IASLC’s Spotlight on Screening
lungcanc
4th AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the...
lungcanc
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
lungcanc
IASLC and APLCC Present 7th IASLC Asia Pacific Lung Cancer Conference
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
